{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:18:01Z","timestamp":1792783081318,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82474597"],"award-info":[{"award-number":["82474597"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10735-026-11001-z","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:20:44Z","timestamp":1792066844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative therapy with Qinghao Biejia Decoction improves survival after resection of intrahepatic cholangiocarcinoma"],"prefix":"10.1007","volume":"57","author":[{"given":"Jue","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoshui","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengke","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lide","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"issue":"9","key":"11001_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen JB, Braconi C, Calvisi DF, Perugorria MJ, Fabris L, Boulter L, Macias RIR, Gaudio E, Alvaro D, Gradilone SA, Strazzabosco M, Marzioni M, Coulouarn C, Fouassier L, Raggi C, Invernizzi P, Mertens JC, Moncsek A, Ilyas SI, Heimbach J, Koerkamp BG, Bruix J, Forner A, Bridgewater J, Valle JW, Gores GJ (2020) Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol 17(9):557\u2013588","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"11001_CR2","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1021\/acsami.4c13433","volume":"17","author":"S Chen","year":"2025","unstructured":"Chen S, Sun Y, Xie Y, Liu Y, Hu H, Xie C, Xu S, Zhang Z, Zhang J, Shen Y, Xu X, Qiu N (2025) Mitochondria-targeted icaritin nanoparticles induce immunogenic cell death in hepatocellular carcinoma. ACS Appl Mater Interfaces 17(2):2899\u20132910","journal-title":"ACS Appl Mater Interfaces"},{"issue":"5","key":"11001_CR3","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/pca.3131","volume":"33","author":"X Cheng","year":"2022","unstructured":"Cheng X, Li BP, Han ZX, Zhang FL, Jiang ZR, Yang JS, Luo QZ, Tang L (2022) Qualitative and quantitative analysis of the major components in Qinghao Biejia decoction by UPLC-Orbitrap Fusion-MS\/MS and UPLC-QQQ-MS\/MS and evaluation of their antibacterial activities. Phytochem Anal 33(5):809\u2013825","journal-title":"Phytochem Anal"},{"issue":"8","key":"11001_CR4","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1200\/JCO.18.00050","volume":"37","author":"J Edeline","year":"2019","unstructured":"Edeline J, Benabdelghani M, Bertaut A, Watelet J, Hammel P, Joly JP, Boudjema K, Fartoux L, Bouhier-Leporrier K, Jouve JL, Faroux R, Guerin-Meyer V, Kurtz JE, Ass\u00e9nat E, Seitz JF, Baumgaertner I, Tougeron D, de la Fouchardi\u00e8re C, Lombard-Bohas C, Boucher E, Stanbury T, Louvet C, Malka D, Phelip JM (2019) Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): a randomized phase III study. J Clin Oncol 37(8):658\u2013667","journal-title":"J Clin Oncol"},{"issue":"3","key":"11001_CR5","first-page":"14","volume":"81","author":"General Assembly of the World Medical, A.","year":"2014","unstructured":"General Assembly of the World Medical, A. (2014) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Coll Dent 81(3):14\u201318","journal-title":"J Am Coll Dent"},{"issue":"1","key":"11001_CR6","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, Li B (2021) Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther 6(1):425","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"11001_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.hpb.2015.07.006","volume":"18","author":"Z Jutric","year":"2016","unstructured":"Jutric Z, Johnston WC, Hoen HM, Newell PH, Cassera MA, Hammill CW, Wolf RF, Hansen PD (2016) Impact of lymph node status in patients with intrahepatic cholangiocarcinoma treated by major hepatectomy: a review of the National Cancer Database. HPB (Oxford) 18(1):79\u201387","journal-title":"HPB (Oxford)"},{"issue":"1","key":"11001_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12943-024-02213-6","volume":"24","author":"S Li","year":"2025","unstructured":"Li S, Chen X, Shi H, Yi M, Xiong B, Li T (2025) Tailoring traditional Chinese medicine in cancer therapy. Mol Cancer 24(1):27","journal-title":"Mol Cancer"},{"key":"11001_CR9","doi-asserted-by":"crossref","unstructured":"Liu Z, Liu J, Tang W, Pratap UP, Altwegg KA, Li X, Viswanadhapalli S, Vadlamudi R (2021) Abstract PS17\u201334: proto-oncogene PELP1 interactions with SETDB1 contribute to aberrant activation of AKT1 in breast cancer. Cancer Res 81(4_Supplement): PS17\u201334-PS17\u201334","DOI":"10.1158\/1538-7445.SABCS20-PS17-34"},{"issue":"4","key":"11001_CR10","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1007\/s12029-024-01113-8","volume":"55","author":"P Mattiolo","year":"2024","unstructured":"Mattiolo P, De Bellis M, Mafficini A, Fassan M, Bevere M, Ciulla C, Bersani S, Lawlor RT, Milella M, Scarpa A, Luchini C, Ruzzenente A (2024) Long-term survivor of intrahepatic cholangiocarcinoma for over 18 years: case study with longitudinal histo-molecular and tumor immune microenvironment characterization and systematic review of the literature. J Gastrointest Cancer 55(4):1634\u20131646","journal-title":"J Gastrointest Cancer"},{"issue":"6","key":"11001_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-026-04854-4","volume":"16","author":"R Qaisar","year":"2026","unstructured":"Qaisar R, Srinivas M, Ahmad F, Karim A (2026) Hypoxia exacerbates mechanical disuse-induced muscle decline through structural, functional, and molecular reprogramming in mice. 3 Biotech 16(6):231","journal-title":"3 Biotech"},{"key":"11001_CR12","doi-asserted-by":"publisher","unstructured":"Qiu YT, Wang WJ, Zhang B, Mei LL, Shi ZZ (2025) [Corrigendum] MCM7 amplification and overexpression promote cell proliferation, colony formation and migration in esophageal squamous cell carcinoma by activating the AKT1\/mTOR signaling pathway. Oncol Rep. https:\/\/doi.org\/10.3892\/or.2025.8898","DOI":"10.3892\/or.2025.8898"},{"key":"11001_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-60761-806-5_1","volume":"664","author":"R Simon","year":"2010","unstructured":"Simon R (2010) Applications of tissue microarray technology. Methods Mol Biol 664:1\u201316","journal-title":"Methods Mol Biol"},{"issue":"1","key":"11001_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1245\/s10434-015-4642-9","volume":"23","author":"G Spolverato","year":"2016","unstructured":"Spolverato G, Kim Y, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Tran TB, Marsh JW, Pawlik TM (2016) Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative-intent surgical resection. Ann Surg Oncol 23(1):235\u2013243","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"11001_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00535-022-01868-6","volume":"57","author":"Y Suzuki","year":"2022","unstructured":"Suzuki Y, Mori T, Momose H, Matsuki R, Kogure M, Abe N, Isayama H, Tazuma S, Tanaka A, Takikawa H, Sakamoto Y (2022) Predictive factors for subsequent intrahepatic cholangiocarcinoma associated with hepatolithiasis: Japanese national cohort study for 18 years. J Gastroenterol 57(5):387\u2013395","journal-title":"J Gastroenterol"},{"issue":"8","key":"11001_CR16","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/hpb.12441","volume":"17","author":"SM Weber","year":"2015","unstructured":"Weber SM, Ribero D, O\u2019Reilly EM, Kokudo N, Miyazaki M, Pawlik TM (2015) Intrahepatic cholangiocarcinoma: expert consensus statement. HPB (Oxford) 17(8):669\u2013680","journal-title":"HPB (Oxford)"},{"issue":"1","key":"11001_CR17","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12943-024-02136-2","volume":"23","author":"J Wu","year":"2024","unstructured":"Wu J, Tang G, Cheng CS, Yeerken R, Chan YT, Fu Z, Zheng YC, Feng Y, Wang N (2024) Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery. Mol Cancer 23(1):218","journal-title":"Mol Cancer"},{"key":"11001_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1336347","volume":"15","author":"K Xie","year":"2024","unstructured":"Xie K, Ma M, Xu F (2024) Long-term oral administration of Huaier granules improves survival outcomes in hepatocellular carcinoma patients within Milan criteria following microwave ablation: a propensity score matching and stabilized inverse probability weighting analysis. Front Pharmacol 15:1336347","journal-title":"Front Pharmacol"},{"issue":"1","key":"11001_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-92036-2","volume":"15","author":"M Xue","year":"2025","unstructured":"Xue M, Kang L, Zhang Y, Yuan X, Li J, Zhang R, Wong J (2025) AKT1 as a therapeutic target for platinum-resistant SOX2 positive ovarian cancer cells. Sci Rep 15(1):15096","journal-title":"Sci Rep"},{"key":"11001_CR20","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.2147\/DDDT.S414098","volume":"17","author":"Y Ye","year":"2023","unstructured":"Ye Y, Yang Y, Yan L, Zhou L, Yu S, Du Q, Dong X, Yuan Q, Shan L, Guo L (2023) Integrating network pharmacology and experimental validation to explore the effects and mechanisms of Qinghao Biejia decoction and its active compound artemisinin B against non-small-cell lung cancer. Drug des Devel Ther 17:2461\u20132479","journal-title":"Drug des Devel Ther"},{"issue":"26","key":"11001_CR21","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.2174\/0115680266336478241118065659","volume":"25","author":"S Zheng","year":"2025","unstructured":"Zheng S, Gu Y, Qi W, Wang W, Li X, Zao X, Li S, Liu S, Xue T, Ye Y, Liu A (2025) Traditional Chinese medicine for liver cancer treatment: network pharmacology research. Curr Top Med Chem 25(26):3027\u20133041","journal-title":"Curr Top Med Chem"},{"key":"11001_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.110926","volume":"392","author":"X Zhou","year":"2024","unstructured":"Zhou X, Wu D, Mi T, Li R, Guo T, Li W (2024) Icaritin activates p53 and inhibits aerobic glycolysis in liver cancer cells. Chem Biol Interact 392:110926","journal-title":"Chem Biol Interact"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-11001-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-11001-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-11001-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:33:42Z","timestamp":1792085622000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-11001-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11001"],"URL":"https:\/\/doi.org\/10.1007\/s10735-026-11001-z","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"10 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all participants in this study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors acknowledge the use of M365 Copilot as an assistive tool in the preparation of this manuscript. The AI system was consulted for language refinement and text organization, and the resulting text was reviewed, edited, and fact\u2011checked by the authors to ensure accuracy, originality, and compliance with ethical and academic standards. The authors retain full responsibility for the integrity, validity, and originality of all scientific content presented in this manuscript.","order":3,"name":"Ethics","label":"Use of artificial intelligence writing assistance","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"342"}}